Cited by 15,011Multiple Sclerosis Research StudiesHealth Systems, Economic Evaluations, Quality of LifeVoice and Speech Disorders

The DOI matches its Crossref record; 12 of the 13 references it cites were found in a registry or an index.

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Kurtzke, John F.·1983·Neurology

DOI 10.1212/wnl.33.11.1444

Open this paper in CoChat — free account

Abstract

One method of evaluating the degree of neurologic impairment in MS has been the combination of grades (0 = normal to 5 or 6 = maximal impairment) within 8 Functional Systems (FS) and an overall Disability Status Scale (DSS) that had steps from 0 (normal) to 10 (death due to MS). A new Expanded Disability Status Scale (EDSS) is presented, with each of the former steps (1,2,3 . . . 9) now divided into two (1.0, 1.5, 2.0 . . . 9.5). The lower portion is obligatorily defined by Functional System grades. The FS are Pyramidal, Cerebellar, Brain Stem, Sensory, Bowel & Bladder, Visual, Cerebral, and Other; the Sensory and Bowel & Bladder Systems have been revised. Patterns of FS and relations of FS by type and grade to the DSS are demonstrated.

Integrity signals

Registry

Crossref · 10.1212/wnl.33.11.1444

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

On the evaluation of disability in multiple sclerosis
Kurtzke, J. F. (1961) · Neurology · doi:10.1212/wnl.11.8.686 · Cited by 330
Further notes on disability evaluation in multiple sclerosis, with scale modifications
Kurtzke, J. F. (1965) · Neurology · doi:10.1212/wnl.15.7.654 · Cited by 309
A New Scale for Evaluating Disability in Multiple Sclerosis
Kurtzke, J. F. (1955) · Neurology · doi:10.1212/wnl.5.8.580 · Cited by 305
Appreciating the consequences of disease: the international classification of impairments, disabilities, and handicaps.
Wood, P. (1980) · PubMed · Cited by 247
NEUROLOGIC IMPAIRMENT IN MULTIPLE SCLEROSIS AND THE DISABILITY STATUS SCALE
Kurtzke, J. F. (1970) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1970.tb05808.x · Cited by 156
A PROPOSAL FOR A UNIFORM MINIMAL RECORD OF DISABILITY IN MULTIPLE SCLEROSIS
Kurtzke, J. F. (1981) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1981.tb05548.x · Cited by 127
STUDIES ON THE NATURAL HISTORY OF MULTIPLE SCLEROSIS 6. Clinical and Laboratory Findings at First Diagnosis
Kurtzke, J. F., Beebe, G. W., Nagler, B., Auth, T. L., Kurland, L. T., & Nefzger, M. D. (1972) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1972.tb07525.x · Cited by 68
THE SOCIO-ECONOMIC SCALE
Mellerup, E., Fog, T., Raun, N. E., Colville, P., de Rham, B., Hannah, B., & Kurtzke, J. F. (1981) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1981.tb05549.x · Cited by 53
The effects of isoniazid on patients with multiple sclerosis; preliminary report.
Kurtzke, J. F., & Berlin, L. (1954) · PubMed · doi:10.1164/art.1954.70.4.577 · Cited by 23
ACUTE RESPIRATORY FAILURE IN MULTIPLE SCLEROSIS AND ITS MANAGEMENT
Guthrie, T. C., Kurtzke, J. F., & BERLIN, L. (1952) · Annals of Internal Medicine · doi:10.7326/0003-4819-37-6-1197 · Cited by 20

Show all 13 references

Sorted by citations

Items 301–400 of 1,135

Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.
Benedict, R., Bruce, J. M., Dwyer, M., Abdelrahman, N., Hussein, S., Weinstock-Guttman, B., Garg, N., Munschauer, F., & Zivadinov, R. (2006) · Archives of Neurology · doi:10.1001/archneur.63.9.1301 · Cited by 323
Western versus asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders
Yamasaki, K., Kira, J., Kawano, Y., Kobayashi, T., Kanai, T., Nishimura, Y., Matsushita, S., Hasuo, K., & Tobimatsu, S. (1996) · Annals of Neurology · doi:10.1002/ana.410400405 · Cited by 301
Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls
Gold, S. M., Schulz, K., Hartmann, S., Mladek, M., Lang, U. E., Hellweg, R., Reer, R., Braumann, K.-M., & Heesen, C. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00121-8 · Cited by 311
Donepezil improved memory in multiple sclerosis in a randomized clinical trial
Krupp, L., Christodoulou, C., Melville, P., SCHERL, W. F., MacAllister, W. S., & Elkins, L. E. (2004) · Neurology · doi:10.1212/01.wnl.0000142989.09633.5a · Cited by 300
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS
Sepulcre, J., Murie-Fernández, M., Salinas‐Alamán, A., García‐Layana, A., Bejarano, B., & Villoslada, P. (2007) · Neurology · doi:10.1212/01.wnl.0000260612.51849.ed · Cited by 298
Multiple sclerosis: Comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells
Neuhaus, O., Farina, C., Yassouridis, A., Wiendl, H., Bergh, F. T., Dose, T., Wekerle, H., & Hohlfeld, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7452 · Cited by 299
Employment in multiple sclerosis
Julian, L. J., Vella, L., Vollmer, T. L., Hadjimichael, O. C., & Mohr, D. C. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0910-y · Cited by 298
Optical coherence tomography and disease subtype in multiple sclerosis
Pulicken, M., Gordon‐Lipkin, E. M., Balcer, L. J., Frohman, E. M., Cutter, G., & Calabresi, P. A. (2007) · Neurology · doi:10.1212/01.wnl.0000294876.49861.dc · Cited by 298
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness
Saidha, S., Syc‐Mazurek, S. B., Durbin, M. K., Eckstein, C. P., Oakley, J. D., Meyer, S. A., Conger, A., Frohman, T. C., Newsome, S. D., Ratchford, J. N., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511418630 · Cited by 297
Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis
Sanfilipo, M., Benedict, R., Weinstock-Guttman, B., & Bakshi, R. (2006) · Neurology · doi:10.1212/01.wnl.0000201238.93586.d9 · Cited by 305
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis
Wood, B., van der Mei, I., Ponsonby, A.-L., Pittas, F., Quinn, S., Dwyer, T., Lucas, R., & Taylor, B. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458512450351 · Cited by 294
Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners: Quality of life and emotional well-being in MS
Janssens, A. C. J. W., van Doorn, P. A., de Boer, J. B., van der Meché, F. G. A., Passchier, J., & Hintzen, R. Q. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00166.x · Cited by 294
Correlating MRI and clinical disease activity in multiple sclerosis
van Walderveen, M. A. A., Barkhof, F., Hommes, O. R., Polman, C. H., Tobi, H., Frequin, S. T. F. M., & Valk, J. (1995) · Neurology · doi:10.1212/wnl.45.9.1684 · Cited by 294
HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course
Barcellos, L. F., Oksenberg, J. R., Begovich, A. B., Martin, E. R., Schmidt, S., Vittinghoff, E., Goodin, D. S., Pelletier, D., Lincoln, R., Bucher, P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367781 · Cited by 293
Fatigue and declines in cognitive functioning in multiple sclerosis
Krupp, L., & Elkins, L. E. (2000) · Neurology · doi:10.1212/wnl.55.7.934 · Cited by 293
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
Kleiter, I. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.216 · Cited by 292
The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis
Sharrack, B., & Hughes, R. A. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500406 · Cited by 290
Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis
Cox, A. L., Thompson, S. A. J., Jones, J., Robertson, V. H., Hale, G., Waldmann, H., Compston, D. A. S., & Coles, A. J. (2005) · European Journal of Immunology · doi:10.1002/eji.200535075 · Cited by 291
Gait abnormalities in minimally impaired multiple sclerosis patients
Benedetti, M. G., Piperno, R., Simoncini, L., Bonato, P., Tonini, A., & Giannini, S. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500510 · Cited by 290
Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis
Cercignani, M. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.3.311 · Cited by 287
No cerebrocervical venous congestion in patients with multiple sclerosis
Doepp, F., Paul, F., Valdueza, J. M., Schmierer, K., & Schreiber, S. J. (2010) · Annals of Neurology · doi:10.1002/ana.22085 · Cited by 290
Health-related Quality of Life in Multiple Sclerosis: The Impact of Disability, Gender and Employment Status
Miller, A., & Dishon, S. (2006) · Quality of Life Research · doi:10.1007/s11136-005-0891-6 · Cited by 298
The Communicative Participation Item Bank (CPIB): Item Bank Calibration and Development of a Disorder-Generic Short Form
Baylor, C. R., Yorkston, K. M., Eadie, T. L., Kim, J., Chung, H., & Amtmann, D. (2013) · Journal of Speech Language and Hearing Research · doi:10.1044/1092-4388(2012/12-0140 · Cited by 306
Body-worn motion sensors detect balance and gait deficits in people with multiple sclerosis who have normal walking speed
Spain, R., George, R. J. S., Salarian, A., Mancini, M., Wagner, J. M., Horak, F. B., & BOURDETTE, D. N. (2012) · Gait & Posture · doi:10.1016/j.gaitpost.2011.11.026 · Cited by 287
Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.
Thompson, A. J., Kermode, A. G., MacManus, D. G., Kendall, B. E., Kingsley, D. P. E., MOSELEY, I. F., & McDonald, W. I. (1990) · BMJ · doi:10.1136/bmj.300.6725.631 · Cited by 287
Untitled work
(2000) · doi:10.1002/1531-8249(200012)48:6
Cognitive and psychosocial features of childhood and juvenile MS
Amato, M. P., Goretti, B., Ghezzi, A., Lori, S., Zipoli, V., Portaccio, E., Moiola, L., Falautano, M., Caro, M. F. D., López, M. D. P. S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000312276.23177.fa · Cited by 287
Validity of performance scales for disability assessment in multiple sclerosis
Marrie, R. A., & Goldman, M. D. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507078388 · Cited by 286
Costs and quality of life in multiple sclerosis
Kobelt, G., Berg, J., Atherly, D., & Hadjimichael, O. C. (2006) · Neurology · doi:10.1212/01.wnl.0000218309.01322.5c · Cited by 288
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial
Gold, R., Giovannoni, G., Selmaj, K. W., Havrdová, E., Montalbán, X., Radue, E. W., Stefoski, D., Robinson, R. R., Riester, K. A., Rana, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62190-4 · Cited by 286
Quantifying the local tissue volume and composition in individual brains with magnetic resonance imaging
Mezer, A., Yeatman, J. D., Stikov, N., Kay, K., Cho, N., Dougherty, R. F., Perry, L. M., Parvizi, J., Hua, L. H., Pauly, K. B., et al. (2013) · Nature Medicine · doi:10.1038/nm.3390 · Cited by 276
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study
Burt, R. K., Loh, Y., Cohen, B. A., Stefoski, D., Balabanov, R. D., Katsamakis, G., Oyama, Y., Russell, E. J., Stern, J. L., Muraro, P. A., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70017-1 · Cited by 285
Cladribine in treatment of chronic progressive multiple sclerosis
Sipe, J. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91046-4 · Cited by 279
Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function
Khatri, B. O., Man, S., Giovannoni, G., Koo, A. P., Lee, J., Tucky, B. H., Lynn, F., Jurgensen, S., Woodworth, J. R., Goelz, S. E., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000341766.59028.9d · Cited by 282
Baseline MRI predicts future attacks and disability in clinically isolated syndromes
Tintoré, M., Rovira, À., Río, J., Nos, C., Grivé, E., Téllez, N., Pelayo, R., Comabella, M., Sastre‐Garriga, J., & Montalbán, X. (2006) · Neurology · doi:10.1212/01.wnl.0000237354.10144.ec · Cited by 282
Antigen-Specific Tolerance by Autologous Myelin Peptide–Coupled Cells: A Phase 1 Trial in Multiple Sclerosis
Lutterotti, A., Yousef, S., Sputtek, A., Stürner, K. H., Stellmann, J., Breiden, P., Reinhardt, S., Schulze, C., Bester, M., Heesen, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006168 · Cited by 282
Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.
Chard, D., Griffin, C., McLean, M., Kapeller, P., Kapoor, R., Thompson, A., & Miller, D. (2002) · Brain : a journal of neurology · doi:10.1093/brain/awf240 · Cited by 288
Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant
Steenwijk, M. D., Geurts, J. J. G., Daams, M., Tijms, B. M., Wink, A. M., Balk, L. J., Tewarie, P. K. B., Uitdehaag, B. M. J., Barkhof, F., Vrenken, H., et al. (2015) · Brain · doi:10.1093/brain/awv337 · Cited by 280
Validity of the Timed Up and Go Test as a Measure of Functional Mobility in Persons With Multiple Sclerosis
Sebastião, É., Sandroff, B. M., Learmonth, Y. C., & Motl, R. W. (2016) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2015.12.031 · Cited by 282
Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation
Schmierer, K., Wheeler‐Kingshott, C. A. M., Tozer, D. J., Boulby, P. A., Parkes, H. G., Yousry, T. A., Scaravilli, F., Barker, G. J., Tofts, P. S., & Miller, D. H. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21487 · Cited by 281
MULTIPLE SCLEROSIS AND THE UROLOGIST
Litwiller, S. E., Frohman, E. M., & Zimmern, P. E. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61760-9 · Cited by 281
Quantitative Susceptibility Mapping in Multiple Sclerosis
Langkammer, C., Liu, T., Khalil, M., Enzinger, C., Jehna, M., Fuchs, S., Fazekas, F., Wang, Y., & Ropele, S. (2013) · Radiology · doi:10.1148/radiol.12120707 · Cited by 281
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
Collin, C., Ehler, E., Waberzinek, G., Alsindi, Z., Davies, P., Powell, K., Notcutt, W., O'Leary, C., Ratcliffe, S., Nováková, I., et al. (2010) · Neurological Research · doi:10.1179/016164109x12590518685660 · Cited by 283
The nature of memory impairments in multiple sclerosis: Acquisition versus retrieval
DeLuca, J., Barbieri-berger, S., & Johnson, S. K. (1994) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639408402629 · Cited by 280
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability
Carotenuto, A., Cacciaguerra, L., Pagani, E., Preziosa, P., Filippi, M., & Rocca, M. A. (2021) · Brain · doi:10.1093/brain/awab454 · Cited by 288
Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis
Tur, C., Carbonell‐Mirabent, P., Cobo‐Calvo, Á., Otero‐Romero, S., Arrambide, G., Midaglia, L. S., Castilló, J., Vidal‐Jordana, Á., Rodrı́guez‐Acevedo, B., Zabalza, A., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.4655 · Cited by 281
Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1–associated myelopathy (HAM/TSP)
Yamano, Y., Nagai, M., Brennan, M. B., Mora, C. A., Soldan, S. S., Tomaru, U., Takenouchi, N., Izumo, S., Osame, M., & Jacobson, S. (2002) · Blood · doi:10.1182/blood.v99.1.88 · Cited by 277
Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis
Sørensen, P. S., Lisby, S., Grove, R. A., Derosier, F. J., Shackelford, S., Havrdová, E., Drulovic, J. S., & Filippi, M. (2014) · Neurology · doi:10.1212/wnl.0000000000000125 · Cited by 275
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
Zajicek, J., Hobart, J. C., Slade, A. L., Barnes, D., & Mattison, P. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302468 · Cited by 277
Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS
Huijbregts, S. C. J., Kalkers, N. F., de Sonneville, L. M. J., de Groot, V., Reuling, I. E. W., & Polman, C. H. (2004) · Neurology · doi:10.1212/01.wnl.0000129828.03714.90 · Cited by 277
Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition
Bruce, J. M., Hancock, L. M., Arnett, P., & Lynch, S. (2010) · Journal of behavioral medicine · doi:10.1007/s10865-010-9247-y · Cited by 297
A Randomized Controlled Trial of Cognitive Behavior Therapy for Multiple Sclerosis Fatigue
van Kessel, K., Moss-Morris, R., Willoughby, E., Chalder, T., Johnson, M. H., & Robinson, E. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181643065 · Cited by 276
Quantitative Magnetization Transfer Imaging in Postmortem Multiple Sclerosis Brain
Schmierer, K., Tozer, D., Scaravilli, F., Altmann, D., Barker, G. J., Tofts, P., & Miller, D. H. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20984 · Cited by 296
Resistance training improves muscle strength and functional capacity in multiple sclerosis
Dalgas, U., Stenager, E., Jakobsen, J., Petersen, T., Hansen, H. J., Knudsen, C., Overgaard, K., & Ingemann-Hansen, T. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bf98b4 · Cited by 275
Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation
Demaree, H. A., DeLuca, J., Gaudino, E. A., & Diamond, B. J. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.5.661 · Cited by 274
Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis.
Betts, C. D., D'Mellow, M. T., & Fowler, C. J. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.3.245 · Cited by 274
Digital Twins for Multiple Sclerosis
Voigt, I., Inojosa, H., Dillenseger, A., Haase, R., Akgün, K., & Ziemssen, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669811 · Cited by 294
The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics
Minden, S. L., Frankel, D., Hadden, L., Perloff, J., Srinath, K. P., & Hoaglin, D. C. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1262oa · Cited by 272
Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese
Matsuoka, T., Matsushita, T., Kawano, Y., Osoegawa, M., Ochi, H., Ishizu, T., Minohara, M., Kikuchi, H., Mihara, F., Ohyagi, Y., et al. (2007) · Brain · doi:10.1093/brain/awm027 · Cited by 272
Balance, gait, and falls in multiple sclerosis
(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-63916-5.00015-x · Cited by 271
Anti-spasticity agents for multiple sclerosis
Shakespeare, D. T., Boggild, M., & Young, C. A. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001332 · Cited by 271
Psychological interventions for multiple sclerosis.
Thomas, P. W., Thomas, S., Hillier, C., Galvin, K., & Baker, R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004431.pub2 · Cited by 271
New natural history of interferon‐β–treated relapsing multiple sclerosis
Trojano, M., Pellegrini, F., Fuiani, A., Paolicelli, D., Zipoli, V., Zimatore, G., Monte, E. D., Portaccio, E., Lepore, V., Livrea, P., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21102 · Cited by 260
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome
Millefiorini, E., Gasperini, C., Pozzilli, C., D'Andrea, F., Bozzao, A., Calò, A., Bernini, M. L., Gambi, D., Prencipe, M., Bastianello, S., et al. (1997) · Journal of Neurology · doi:10.1007/s004150050066 · Cited by 268
Potassium channel blockers in multiple sclerosis: Neuronal Kv channels and effects of symptomatic treatment
Judge, S. I. V., & Bever, C. T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.006 · Cited by 274
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis
Tütüncü, M., Tang, J., Zeid, N. E. A., Kale, N., Crusan, D. J., Atkinson, E. J., Sıva, A., Pittock, S. J., Pirko, I., Keegan, B. M., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512451510 · Cited by 280
Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy
Ziemssen, T. (2002) · Brain · doi:10.1093/brain/awf252 · Cited by 268
Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of multiple sclerosis
Audoin, B., Ibarrola, D., Ranjeva, J., Sylviane Confort-gouny, A., Irina Malikova, A., Ali‐Chérif, A., Pelletier, J., & Cozzone, P. J. (2003) · Human Brain Mapping · doi:10.1002/hbm.10128 · Cited by 265
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial
Coles, A. J., Fox, E., Vladić, A., Gazda, S. K., Brinar, V. V., Selmaj, K. W., Skoromets, A. A., Stolyarov, I. D., Bass, A. D.-D., Sullivan, H., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31824e8ee7 · Cited by 266
Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups
Zorzon, M., Zivadinov, R., Bosco, A., Bragadin, L. M., Moretti, R., Bonfigli, L., Morassi, P., Iona, L., & Cazzato, G. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500i609 · Cited by 274
Factors related to employment status changes in individuals with multiple sclerosis
Smith, M., & Arnett, P. A. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1204oa · Cited by 269
From genotype to phenotype: A clinical, pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation
Nasreddine, Z. S., Loginov, M., Clark, L. N., Lamarche, J. B., Miller, B. L., Lamontagne, A., Zhukareva, V. A., Lee, V. M. ‐., Wilhelmsen, K. C., & Geschwind, D. H. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199906)45:6 · Cited by 135
Adjustment to multiple sclerosis: Application of a stress and coping model.
Pakenham, K. I. (1999) · Health Psychology · doi:10.1037//0278-6133.18.4.383 · Cited by 265
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Kappos, L., Wiendl, H., Selmaj, K. W., Arnold, D. L., Havrdová, E., Boyко, A., Kaufman, M., ROSE, J. W., Greenberg, S. J., Sweetser, M. T., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501481 · Cited by 264
Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests.
Goodkin, D. E., Hertsgaard, D., & Seminary, J. (1988) · PubMed · Cited by 263
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders
Banwell, B., Tenembaum, S. N., Lennon, V. A., Ursell, E., Kennedy, J., Bar‐Or, A., Weinshenker, B. G., Lucchinetti, C. F., & Pittock, S. J. (2007) · Neurology · doi:10.1212/01.wnl.0000284600.80782.d5 · Cited by 263
Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis
Shirani, A., Zhao, Y., Karim, M. E., Evans, C. D., Kingwell, E., van der Kop, M. L., Oger, J. J.-F., Gustafson, P., Petkau, J., & Tremlett, H. L. (2012) · JAMA · doi:10.1001/jama.2012.7625 · Cited by 263
Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study
Andersen, O., Lygner, P.-E., Bergström, T. B., Andersson, M., & Vablne, A. (1993) · Journal of Neurology · doi:10.1007/bf00867354 · Cited by 263
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study
Vaney, C., Heinzel‐Gutenbrunner, M., Jobin, P., Tschopp, F., Gattlen, B., Hagen, U., Schnelle, M., & Reif, M. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1048oa · Cited by 266
Guidelines for Neuropsychological Research in Multiple Sclerosis
Peyser, J. M., Rao, S. M., LaRocca, N. G., & Kaplan, E. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530010120030 · Cited by 263
Neutrophil-related factors as biomarkers in EAE and MS
Rumble, J. M., Huber, A. K., Krishnamoorthy, G., Srinivasan, A., Giles, D. A., Zhang, X., Wang, L., & Segal, B. M. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20141015 · Cited by 262
Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease
Williet, N., Sandborn, W. J., & Peyrin–Biroulet, L. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.02.016 · Cited by 260
Mortality in patients with multiple sclerosis
Scalfari, A., Knappertz, V. A., Cutter, G., Goodin, D. S., Ashton, R., & Ebers, G. C. (2013) · Neurology · doi:10.1212/wnl.0b013e31829a3388 · Cited by 280
Reliable screening for neuropsychological impairment in multiple sclerosis
Benedict, R. H. B., Cox, D., Thompson, L. L., Foley, F., Weinstock‐Guttman, B., & Munschauer, F. E. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1098oa · Cited by 261
Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data
Eshaghi, A., Young, A. L., Wijeratne, P. A., Prados, F., Arnold, D. L., Narayanan, S., Guttmann, C. R. G., Barkhof, F., Alexander, D. C., Thompson, A. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22265-2 · Cited by 281
Probiotic helminth administration in relapsing–remitting multiple sclerosis: a phase 1 study
Fleming, J. O., Isaak, A., Lee, J., Luzzio, C. C., Carrithers, M. D., Cook, T., Field, A. S., Boland, J., & Fábry, Z. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511398054 · Cited by 257
Neuropsychological Aspects of Multiple Sclerosis
Brassington, J., & Marsh, N. V. (1998) · Neuropsychology Review · doi:10.1023/a:1025621700003 · Cited by 258
Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis
Kent‐Braun, J. A., Ng, A., Castro, M. J., Weiner, M. W., Gelinas, D. F., Dudley, G. A., & Miller, R. G. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.6.1998 · Cited by 258
The psychometric properties of clinical rating scales used in multiple sclerosis
Sharrack, B., Hughes, R. A., Soudain, S., & Dunn, G. (1999) · Brain · doi:10.1093/brain/122.1.141 · Cited by 263
Persistent pain and uncomfortable sensations in persons with multiple sclerosis
Hadjimichael, O. C., Kerns, R. D., Rizzo, M., Cutter, G., & Vollmer, T. L. (2006) · Pain · doi:10.1016/j.pain.2006.07.015 · Cited by 263
Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: Application in multiple sclerosis
Horsfield, M. A., Sala, S., Neema, M., Absinta, M., Bakshi, A., Sormani, M. P., Rocca, M. A., Bakshi, R., & Filippi, M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.121 · Cited by 257
Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis
Kühle, J., Pohl, C., Mehling, M., Edan, G., Freedman, M. S., Hartung, H., Polman, C. H., Miller, D. H., Montalbán, X., Barkhof, F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063602 · Cited by 256
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis
Stefano, N. D., Stromillo, M. L., Giorgio, A., Bartolozzi, M. L., Battaglini, M., Baldini, M., Portaccio, E., Amato, M. P., & Sormani, M. P. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309903 · Cited by 256
MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood
Mikaeloff, Y. (2004) · Brain · doi:10.1093/brain/awh218 · Cited by 256
Multiple Sclerosis: Low-Frequency Temporal Blood Oxygen Level–Dependent Fluctuations Indicate Reduced Functional Connectivity—Initial Results
Lowe, M. J., Phillips, M. D., Lurito, J. T., Mattson, D. H., Džemidžić, M., & Mathews, V. P. (2002) · Radiology · doi:10.1148/radiol.2241011005 · Cited by 256
The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis
The Canadian Cooperative Multiple Sclerosis Study Group (1991) · The Lancet · doi:10.1016/0140-6736(91)93389-q · Cited by 256
Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes
Rocca, M. A., Colombo, B., Falini, A., Ghezzi, A., Martinelli, V., Scotti, G., Comı, G., & Filippi, M. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70171-x · Cited by 251
Exercise Training Guidelines for Multiple Sclerosis, Stroke, and Parkinson Disease
Kim, Y., Lai, B. W., Mehta, T. S., Thirumalai, M., Padalabalanarayanan, S., Rimmer, J. H., & Motl, R. W. (2019) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001174 · Cited by 264
Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients
Willoughby, E. W., Grochowski, E., Li, D. K. B., Oger, J., Kastrukoff, L. F., & Paty, D. W. (1989) · Annals of Neurology · doi:10.1002/ana.410250107 · Cited by 254
Cognitive impairment in probable multiple sclerosis
Achiron, A. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.4.443 · Cited by 252

Authors: Kurtzke, J. F.
Affiliations: Georgetown University (US)
Corresponding author: Kurtzke, John F.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1983-11
Volume: 33
Issue: 11
Pages: 1444-1444
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.33.11.1444
OpenAlex: W2112165124
Cited by: 15,011
References: 13
Citations by year: 2026: 474 · 2025: 622 · 2024: 692 · 2023: 648 · 2022: 722 · 2021: 781 · 2020: 764 · 2019: 648 · 2018: 603 · 2017: 592 · 2016: 657 · 2015: 634 · 2014: 632 · 2013: 586 · 2012: 581
FWCI: 9.57
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
Keywords: multiple sclerosis, Expanded Disability Status Scale, disability assessment, neurological deficit, functional systems, pyramidal system, cerebellar function, brainstem, sensory impairment, bowel and bladder dysfunction, visual impairment
MeSH terms: Humans, Multiple Sclerosis, Nervous System Diseases, Neurologic Examination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks